Personalised cancer prevention
Personalised cancer prevention is based on assessing a person’s genetic risk and providing corresponding medical recommendations. It is a modern, evidence-based healthcare service grounded in recent international scientific research.
New technologies make it possible to detect genetic risk even in individuals who have no family history of cancer or known gene mutations.
We use Antegene polygenic risk score tests, which assess a person’s genetic risk for breast cancer (AnteBC) and prostate cancer (AntePC).
Important
Genetic tests do not show whether a disease will or will not definitely occur, but provide valuable information about predisposition. This helps to make informed decisions about your health and disease prevention.
What is your genetic risk level for breast or prostate cancer?
Contact us if you:
- want to assess your genetic risk level for breast or prostate cancer
- want to know at what age you should start breast cancer screening and how often you should do it
- Personalised breast cancer prevention
- recommended from the age of 30, the genetic test is done only once in a lifetime
the test is done using a cheek swab - results are available within 6 weeks and are also visible to doctors in the Health Portal
- possible further breast cancer examinations within the breast cancer screening programme are free of charge with referrals
- we offer the option of a post-test consultation
4
In Estonia, on average every
fourth woman develops cancer during her lifetime.
49%
Only 49% of breast cancer cases
are detected at an early stage at the time of diagnosis.
99%
There is a 99% chance of
recovery if breast cancer is detected at an early stage.
What is a polygenic risk score test and how does it help?
Reduce disease risks
Antegenes’ comprehensive approach helps prevent common diseases and improves treatment effectiveness. Your health is in your hands.
